secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001628280-22-031632
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals prices $65M public offering of common stock and warrants
---------------------------------------------------------------------------

- Offering includes 52.3M shares and 6.8M pre-funded warrants at $1.10/share.
- Class C warrants to purchase 29.55M shares at $1.50/share, expiring Dec 2027.
- Gross proceeds $65M; net proceeds ~$59.8M after discounts and expenses.
- Underwriters granted 30-day option for up to 8.865M additional shares.
- Closing expected Dec 9, 2022; Piper Sandler, Stifel, Cantor as joint bookrunners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828022031632/0001628280-22-031632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828022031632/xfor-20221206.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-031632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer